BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shi X, Wei X, Yin X, Wang Y, Zhang M, Zhao C, Zhao H, McClain CJ, Feng W, Zhang X. Hepatic and fecal metabolomic analysis of the effects of Lactobacillus rhamnosus GG on alcoholic fatty liver disease in mice. J Proteome Res 2015;14:1174-82. [PMID: 25592873 DOI: 10.1021/pr501121c] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 6.9] [Reference Citation Analysis]
Number Citing Articles
1 Jiang X, Lin D, Shao H, Yang X. Antioxidant properties of Komagataeibacter hansenii CGMCC 3917 and its ameliorative effects on alcohol-induced liver injury in mice. CyTA - Journal of Food 2019;17:355-64. [DOI: 10.1080/19476337.2019.1584647] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 He F, Zhai J, Zhang L, Liu D, Ma Y, Rong K, Xu Y, Ma J. Variations in gut microbiota and fecal metabolic phenotype associated with Fenbendazole and Ivermectin Tablets by 16S rRNA gene sequencing and LC/MS-based metabolomics in Amur tiger. Biochemical and Biophysical Research Communications 2018;499:447-53. [DOI: 10.1016/j.bbrc.2018.03.158] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
3 Zheng TX, Pu SL, Tan P, Du YC, Qian BL, Chen H, Fu WG, Huang MZ. Liver Metabolomics Reveals the Effect of Lactobacillus reuteri on Alcoholic Liver Disease.Front Physiol. 2020;11:595382. [PMID: 33281626 DOI: 10.3389/fphys.2020.595382] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
4 Su H, Xie L, Xu Y, Ke H, Bao T, Li Y, Chen W. Pelargonidin-3- O -glucoside Derived from Wild Raspberry Exerts Antihyperglycemic Effect by Inducing Autophagy and Modulating Gut Microbiota. J Agric Food Chem 2020;68:13025-37. [DOI: 10.1021/acs.jafc.9b03338] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
5 Cheng W, Lu J, Li B, Lin W, Zhang Z, Wei X, Sun C, Chi M, Bi W, Yang B, Jiang A, Yuan J. Effect of Functional Oligosaccharides and Ordinary Dietary Fiber on Intestinal Microbiota Diversity. Front Microbiol 2017;8:1750. [PMID: 28979240 DOI: 10.3389/fmicb.2017.01750] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 10.8] [Reference Citation Analysis]
6 Barve A, Marsano LS, Parajuli D, Cave M, Mcclain CJ. Alcoholic Liver Disease. In: Saeian K, Shaker R, editors. Liver Disorders. Cham: Springer International Publishing; 2017. pp. 173-97. [DOI: 10.1007/978-3-319-30103-7_13] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
7 Kim S, Yin X, Prodhan MAI, Zhang X, Zhong Z, Kato I. Global Plasma Profiling for Colorectal Cancer-Associated Volatile Organic Compounds: a Proof-of-Principle Study. J Chromatogr Sci 2019;57:385-96. [PMID: 30796770 DOI: 10.1093/chromsci/bmz011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
8 Deda O, Virgiliou C, Orfanidis A, Gika HG. Study of Fecal and Urinary Metabolite Perturbations Induced by Chronic Ethanol Treatment in Mice by UHPLC-MS/MS Targeted Profiling. Metabolites 2019;9:E232. [PMID: 31623107 DOI: 10.3390/metabo9100232] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
9 Ghini V, Tenori L, Pane M, Amoruso A, Marroncini G, Squarzanti DF, Azzimonti B, Rolla R, Savoia P, Tarocchi M, Galli A, Luchinat C. Effects of Probiotics Administration on Human Metabolic Phenotype. Metabolites 2020;10:E396. [PMID: 33036487 DOI: 10.3390/metabo10100396] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Li F, Duan K, Wang C, McClain C, Feng W. Probiotics and Alcoholic Liver Disease: Treatment and Potential Mechanisms. Gastroenterol Res Pract. 2016;2016:5491465. [PMID: 26839540 DOI: 10.1155/2016/5491465.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Meng X, Li S, Li Y, Gan RY, Li HB. Gut Microbiota's Relationship with Liver Disease and Role in Hepatoprotection by Dietary Natural Products and Probiotics. Nutrients. 2018;10:1457. [PMID: 30297615 DOI: 10.3390/nu10101457] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 10.8] [Reference Citation Analysis]
12 Prodhan MAI, McClain C, Zhang X. Comprehensive Two-Dimensional Gas Chromatography Mass Spectrometry-Based Metabolomics. Adv Exp Med Biol 2021;1280:57-67. [PMID: 33791974 DOI: 10.1007/978-3-030-51652-9_4] [Reference Citation Analysis]
13 Kirpich IA, Parajuli D, McClain CJ. Microbiome in NAFLD and ALD. Clin Liver Dis (Hoboken) 2015;6:55-8. [PMID: 26576267 DOI: 10.1002/cld.494] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
14 Rojo D, Méndez-García C, Raczkowska BA, Bargiela R, Moya A, Ferrer M, Barbas C. Exploring the human microbiome from multiple perspectives: factors altering its composition and function. FEMS Microbiol Rev 2017;41:453-78. [PMID: 28333226 DOI: 10.1093/femsre/fuw046] [Cited by in Crossref: 70] [Cited by in F6Publishing: 63] [Article Influence: 14.0] [Reference Citation Analysis]
15 Lew LC, Hor YY, Jaafar MH, Lau AS, Khoo BY, Sasidharan S, Choi SB, Ong KL, Kato T, Nakanishi Y, Ohno H, Liong MT. Effects of Potential Probiotic Strains on the Fecal Microbiota and Metabolites of D-Galactose-Induced Aging Rats Fed with High-Fat Diet. Probiotics Antimicrob Proteins 2020;12:545-62. [PMID: 31301059 DOI: 10.1007/s12602-019-09545-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Wu D, Yang J, Yang F, Zhang B, Du J, Wang Y, Xu R. Analysis of Alkaline and Neutral Volatile Metabolites in Feces by Gas Chromatography-Tandem Mass Spectrometry. Chinese Journal of Analytical Chemistry 2017;45:837-43. [DOI: 10.1016/s1872-2040(17)61019-3] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
17 Kirpich IA, Miller ME, Cave MC, Joshi-Barve S, McClain CJ. Alcoholic Liver Disease: Update on the Role of Dietary Fat. Biomolecules 2016;6:1. [PMID: 26751488 DOI: 10.3390/biom6010001] [Cited by in Crossref: 43] [Cited by in F6Publishing: 33] [Article Influence: 7.2] [Reference Citation Analysis]
18 Karu N, Deng L, Slae M, Guo AC, Sajed T, Huynh H, Wine E, Wishart DS. A review on human fecal metabolomics: Methods, applications and the human fecal metabolome database. Analytica Chimica Acta 2018;1030:1-24. [DOI: 10.1016/j.aca.2018.05.031] [Cited by in Crossref: 91] [Cited by in F6Publishing: 85] [Article Influence: 22.8] [Reference Citation Analysis]
19 Su H, Mo J, Ni J, Ke H, Bao T, Xie J, Xu Y, Xie L, Chen W. Andrographolide Exerts Antihyperglycemic Effect through Strengthening Intestinal Barrier Function and Increasing Microbial Composition of Akkermansia muciniphila. Oxid Med Cell Longev 2020;2020:6538930. [PMID: 32774682 DOI: 10.1155/2020/6538930] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
20 Kanmani P, Suganya K, Kim H. The Gut Microbiota: How Does It Influence the Development and Progression of Liver Diseases.Biomedicines. 2020;8:501. [PMID: 33207562 DOI: 10.3390/biomedicines8110501] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
21 Fuenzalida C, Dufeu MS, Poniachik J, Roblero JP, Valenzuela-Pérez L, Beltrán CJ. Probiotics-Based Treatment as an Integral Approach for Alcohol Use Disorder in Alcoholic Liver Disease. Front Pharmacol 2021;12:729950. [PMID: 34630107 DOI: 10.3389/fphar.2021.729950] [Reference Citation Analysis]
22 Lin D, Jiang X, Zhao Y, Zhai X, Yang X. Komagataeibacter hansenii CGMCC 3917 alleviates alcohol-induced liver injury by regulating fatty acid metabolism and intestinal microbiota diversity in mice. Food Funct 2020;11:4591-604. [PMID: 32432239 DOI: 10.1039/c9fo02040c] [Reference Citation Analysis]
23 Guo C, Chen L, Huang J, Wang Y, Shi C, Gao J, Hong Y, Chen T, Qiu L. Aldose reductase inhibitor protects mice from alcoholic steatosis by repressing saturated fatty acid biosynthesis. Chem Biol Interact 2018;287:41-8. [PMID: 29630881 DOI: 10.1016/j.cbi.2018.04.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
24 Hua Y, Cao H, Wang J, He F, Jiang G. Gut microbiota and fecal metabolites in captive and wild North China leopard (Panthera pardus japonensis) by comparsion using 16 s rRNA gene sequencing and LC/MS-based metabolomics. BMC Vet Res 2020;16:363. [PMID: 32993639 DOI: 10.1186/s12917-020-02583-1] [Reference Citation Analysis]
25 Chung HJ, Sim JH, Min TS, Choi HK. Metabolomics and Lipidomics Approaches in the Science of Probiotics: A Review. J Med Food 2018;21:1086-95. [PMID: 30004273 DOI: 10.1089/jmf.2017.4175] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
26 Prodhan MAI, Yin X, Kim S, McClain C, Zhang X. Surface fitting for calculating the second dimension retention index in comprehensive two-dimensional gas chromatography mass spectrometry. J Chromatogr A 2018;1539:62-70. [PMID: 29395161 DOI: 10.1016/j.chroma.2018.01.049] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
27 Dong X, Wang R, Zhou X, Li P, Yang H. Current mass spectrometry approaches and challenges for the bioanalysis of traditional Chinese medicines. Journal of Chromatography B 2016;1026:15-26. [DOI: 10.1016/j.jchromb.2015.11.048] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
28 Tian TF, Wang SY, Kuo TC, Tan CE, Chen GY, Kuo CH, Chen CS, Chan CC, Lin OA, Tseng YJ. Web Server for Peak Detection, Baseline Correction, and Alignment in Two-Dimensional Gas Chromatography Mass Spectrometry-Based Metabolomics Data. Anal Chem 2016;88:10395-403. [PMID: 27673369 DOI: 10.1021/acs.analchem.6b00755] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
29 Sagi H, Shibuya S, Kato T, Nakanishi Y, Tsuboi A, Moriya S, Ohno H, Miyamoto H, Kodama H, Shimizu T. SOD1 deficiency alters gastrointestinal microbiota and metabolites in mice. Exp Gerontol 2020;130:110795. [PMID: 31805337 DOI: 10.1016/j.exger.2019.110795] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
30 Zhang T, Zhang A, Qiu S, Sun H, Han Y, Guan Y, Wang X. High-throughput metabolomics approach reveals new mechanistic insights for drug response of phenotypes of geniposide towards alcohol-induced liver injury by using liquid chromatography coupled to high resolution mass spectrometry. Mol BioSyst 2017;13:73-82. [DOI: 10.1039/c6mb00742b] [Cited by in Crossref: 23] [Cited by in F6Publishing: 8] [Article Influence: 4.6] [Reference Citation Analysis]
31 Tripathi A, Debelius J, Brenner DA, Karin M, Loomba R, Schnabl B, Knight R. Publisher Correction: The gut-liver axis and the intersection with the microbiome. Nat Rev Gastroenterol Hepatol 2018;15:785. [PMID: 29785003 DOI: 10.1038/s41575-018-0031-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
32 Li F, McClain CJ, Feng W. Microbiome dysbiosis and alcoholic liver disease. Liver Res 2019;3:218-26. [PMID: 33868760 DOI: 10.1016/j.livres.2019.09.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
33 Wang W, Li Z, Gan L, Fan H, Guo Y. Dietary supplemental Kluyveromyces marxianus alters the serum metabolite profile in broiler chickens. Food Funct 2018;9:3776-87. [PMID: 29912245 DOI: 10.1039/c8fo00268a] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
34 Tripathi A, Debelius J, Brenner DA, Karin M, Loomba R, Schnabl B, Knight R. The gut-liver axis and the intersection with the microbiome. Nat Rev Gastroenterol Hepatol. 2018;15:397-411. [PMID: 29748586 DOI: 10.1038/s41575-018-0011-z] [Cited by in Crossref: 301] [Cited by in F6Publishing: 300] [Article Influence: 100.3] [Reference Citation Analysis]
35 Guo C, Xue G, Pan B, Zhao M, Chen S, Gao J, Chen T, Qiu L. Myricetin Ameliorates Ethanol-Induced Lipid Accumulation in Liver Cells by Reducing Fatty Acid Biosynthesis. Mol Nutr Food Res 2019;63:e1801393. [PMID: 31168926 DOI: 10.1002/mnfr.201801393] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
36 He L, Li F, Yin X, Bohman P, Kim S, McClain CJ, Feng W, Zhang X. Profiling of Polar Metabolites in Mouse Feces Using Four Analytical Platforms to Study the Effects Of Cathelicidin-Related Antimicrobial Peptide in Alcoholic Liver Disease. J Proteome Res 2019;18:2875-84. [PMID: 31188604 DOI: 10.1021/acs.jproteome.9b00181] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
37 Liu L, Zhao X, Wang Q, Sun X, Xia L, Wang Q, Yang B, Zhang Y, Montgomery S, Meng H. Prosteatotic and Protective Components in a Unique Model of Fatty Liver: Gut Microbiota and Suppressed Complement System. Sci Rep. 2016;6:31763. [PMID: 27550859 DOI: 10.1038/srep31763] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
38 Sarin SK, Pande A, Schnabl B. Microbiome as a therapeutic target in alcohol-related liver disease. Journal of Hepatology 2019;70:260-72. [DOI: 10.1016/j.jhep.2018.10.019] [Cited by in Crossref: 70] [Cited by in F6Publishing: 73] [Article Influence: 23.3] [Reference Citation Analysis]
39 Wei X, Song M, Yin X, Schuschke DA, Koo I, McClain CJ, Zhang X. Effects of Dietary Different Doses of Copper and High Fructose Feeding on Rat Fecal Metabolome. J Proteome Res 2015;14:4050-8. [PMID: 26216400 DOI: 10.1021/acs.jproteome.5b00596] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
40 Li N, Huang S, Jiang L, Wang W, Li T, Zuo B, Li Z, Wang J. Differences in the Gut Microbiota Establishment and Metabolome Characteristics Between Low- and Normal-Birth-Weight Piglets During Early-Life. Front Microbiol 2018;9:1798. [PMID: 30245669 DOI: 10.3389/fmicb.2018.01798] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
41 Li L, Shi M, Salerno S, Tang M, Guo F, Liu J, Feng Y, Fu M, Huang Q, Ma L, Li Y, Fu P. Microbial and metabolomic remodeling by a formula of Sichuan dark tea improves hyperlipidemia in apoE-deficient mice. PLoS One 2019;14:e0219010. [PMID: 31269076 DOI: 10.1371/journal.pone.0219010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
42 Xu J, Zhang Q, Zheng J, Yuan B, Feng Y. Mass spectrometry-based fecal metabolome analysis. TrAC Trends in Analytical Chemistry 2019;112:161-74. [DOI: 10.1016/j.trac.2018.12.027] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
43 Yuan F, Harder J, Ma J, Yin X, Zhang X, Kosiewicz MM. Using Multiple Analytical Platforms to Investigate the Androgen Depletion Effects on Fecal Metabolites in a Mouse Model of Systemic Lupus Erythematosus. J Proteome Res 2020;19:667-76. [PMID: 31820642 DOI: 10.1021/acs.jproteome.9b00558] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
44 Li F, Duan K, Wang C, McClain C, Feng W. Probiotics and Alcoholic Liver Disease: Treatment and Potential Mechanisms. Gastroenterol Res Pract 2016;2016:5491465. [PMID: 26839540 DOI: 10.1155/2016/5491465] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
45 Prodhan MAI, Shi B, Song M, He L, Yuan F, Yin X, Bohman P, McClain CJ, Zhang X. Integrating comprehensive two-dimensional gas chromatography mass spectrometry and parallel two-dimensional liquid chromatography mass spectrometry for untargeted metabolomics. Analyst 2019;144:4331-41. [PMID: 31192319 DOI: 10.1039/c9an00560a] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
46 Joshi-Barve S, Kirpich I, Cave MC, Marsano LS, McClain CJ. Alcoholic, Nonalcoholic, and Toxicant-Associated Steatohepatitis: Mechanistic Similarities and Differences. Cell Mol Gastroenterol Hepatol 2015;1:356-67. [PMID: 28210688 DOI: 10.1016/j.jcmgh.2015.05.006] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 6.1] [Reference Citation Analysis]
47 Bruch-Bertani JP, Uribe-Cruz C, Pasqualotto A, Longo L, Ayres R, Beskow CB, Barth AL, Lima-Morales D, Meurer F, Tayguara Silveira Guerreiro G, da Silveira TR, Álvares-da-Silva MR, Dall'Alba V. Hepatoprotective Effect of Probiotic Lactobacillus rhamnosus GG Through the Modulation of Gut Permeability and Inflammasomes in a Model of Alcoholic Liver Disease in Zebrafish. J Am Coll Nutr 2020;39:163-70. [PMID: 31241423 DOI: 10.1080/07315724.2019.1627955] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
48 Yu M, Jia H, Zhou C, Yang Y, Zhao Y, Yang M, Zou Z. Variations in gut microbiota and fecal metabolic phenotype associated with depression by 16S rRNA gene sequencing and LC/MS-based metabolomics. J Pharm Biomed Anal 2017;138:231-9. [PMID: 28219800 DOI: 10.1016/j.jpba.2017.02.008] [Cited by in Crossref: 113] [Cited by in F6Publishing: 115] [Article Influence: 22.6] [Reference Citation Analysis]